|
It was reported that, after a tka had been performed on (b)(6) 2020, the patient experienced right knee pain and instability.This adverse event was treated by removing the journey ii bcs femoral oxinium right size 3 ((b)(4)) and the jrny ii bcs xlpe art isrt sz 1-2 rt 11mm ((b)(4)) on (b)(6) 2021.Current health status of patient is unknown.
|
|
H6: the device, used in treatment, was not returned for evaluation and the reported event could not be confirmed.The clinical medical investigation concluded that no relevant supporting clinical information has been provided to assist with a clinical investigation.The patient's current condition is unknown and the patient impact beyond the reported events could not be determined based on the limited information provided.Therefore, based on insufficient information, a thorough clinical assessment cannot be performed at this time.Should any additional clinical information be provided this complaint will be re-evaluated.At this time, we have no reason to suspect that the product failed to meet any product specifications at the time of manufacture.A complaint history review found related failures; this failure mode will be monitored for future complaints and assessed for any necessary corrective actions.A review of the risk management file and instructions for use documents revealed this failure mode and potential harm was previously identified.Possible causes could include but not limited to traumatic injury, joint tightness, material in use, patient reaction or loss of sterility.Based on this investigation, the need for corrective action is not indicated.Without the return of the actual product involved or product information, our investigation could not proceed.Should the device or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
|